Fig. 2From: Changes in anticoagulant prescription in Dutch patients with recent-onset atrial fibrillation: observations from the GARFIELD-AF registryTreatment at diagnosis by Class of Recommendation according to the 2016 ESC AF-guidelines (VKA Vitamin K Antagonist, AP Antiplatelet Drug, FXa Factor Xa inhibitor, DTI Direct Thrombin Inhibitor)Back to article page